Cargando…
Add-on administration of ultramicronized palmitoylethanolamide in the treatment of new-onset burning mouth syndrome
AIM: The purpose of this study was to treat burning mouth syndrome (BMS) with a combination of painful gabapentin and ultramicronized palmitoylethanolamide (umPEA), in an attempt to improve the severe symptomatology of BMS. METHODS: We examined the case of a 60-year-old male, suffering from late-ons...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6385774/ https://www.ncbi.nlm.nih.gov/pubmed/30858732 http://dx.doi.org/10.2147/IMCRJ.S194403 |